12
66
10
↑12
↓66
—10
Evidence suggests Vitamin D maydecreaseInflammation.
95 studies (88 claims)
Moderate consensus
Typical effective dose 2800 (2000–200000) IUacross 9 dosed studies
Study Claims
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| combined supplementation of soy isoflavones and active vitamin D | Increases - can improve | some biochemical parameters regarding inflammation and intestinal permeability of IBS | Human | women | 40 mg/day of soy isoflavones. | Soy isoflavones and cholecalciferol reduce inflammation, and gut permeability, without any effect on antioxidant capacity in irritable bowel syndrome: A randomized clinical trial.cited 19× |
| vitamin D supplementation | Decreases - revealed a significant decrease | biomarkers of inflammation and oxidative stress | Human | adults with NAFLD | Not specified | Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials.cited 18× |
| vitamin D supplementation | No effect - showing no beneficial effect | glycemic control and on inflammation | Human | humans | Not specified | Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.cited 93× |
| vitamin D supplementation | Decreases - reduces | inflammation | Human | asthmatic patients | Not specified | The Role of Vitamin D Supplementation on Airway Remodeling in Asthma: A Systematic Review.cited 7× |
| Vitamin D supplementation | Decreases - reduces | inflammation | Human | TBI patients | Not available | Supplement and nutraceutical therapy in traumatic brain injury. |
| Vitamin D supplementation | Decreases - could be useful to mitigate | inflammation | Human | COPD patients | Not available | Anti-inflammatory role of vitamin D in muscle dysfunctions of patients with chronic obstructive pulmonary disease: a comprehensive review.cited 8× |
| Vitamin D supplementation | No effect - revealed no significant effect | inflammation | Human | people | Not specified | The Role of Vitamin D and Its Molecular Bases in Insulin Resistance, Diabetes, Metabolic Syndrome, and Cardiovascular Disease: State of the Art.cited 53× |
| vitamin D supplementation | Decreases - appears to be an efficacious strategy for attenuating | inflammation after exercise | Human | — | Minimum 2000 IU/day. | Effects of vitamin D supplementation on muscle function and recovery after exercise-induced muscle damage: A systematic review.cited 3× |
| vitamin D supplementation | Decreases - may be beneficial in ameliorating | inflammation and dyslipidemia | Human | T2D patients | Not specified | Modulatory Properties of Vitamin D in Type 2 Diabetic Patients: A Focus on Inflammation and Dyslipidemia.cited 8× |
| Vitamin D supplementation | Decreases - attenuates | inflammation in diabetes-associated periodontitis | Human | — | Not specified | A brief review of vitamin D as a potential target for the regulation of blood glucose and inflammation in diabetes-associated periodontitis.cited 8× |
| vitamin D supplementation | No effect - was not associated with lower | inflammatory biomarkers related to type 2 inflammation | Human | individuals with asthma | 800 to 400,000 IU (dose frequency and form not specified). | The effects of vitamin D supplementation on inflammatory biomarkers in patients with asthma: a systematic review and meta-analysis of randomized controlled trials.cited 3× |
| Vitamin D supplementation | Decreases - significantly decreased | lobular inflammation | Human | children | 2000 IU/day. | Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.cited 20× |
| 2000 IU/day vitamin D for 6 months | Decreases - significant improvement | lobular inflammation by liver biopsy | Human | children with biopsy-proven NAFLD | 2000 IU/day. | Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.cited 20× |
| vitamin D supplementation | Decreases - can reduce | low-grade inflammation | Human | — | Not mentioned. | Vitamin D Supplementation: Shedding Light on the Role of the Sunshine Vitamin in the Prevention and Management of Type 2 Diabetes and Its Complications.cited 5× |
| vitamin D supplementation | Decreases - significantly reduced | platelet-mediated inflammation | Human | vitamin-D-deficient T2DM subjects | Not specified in the abstract. | Vitamin D Supplementation Modulates Platelet-Mediated Inflammation in Subjects With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.cited 16× |
| Vitamin D supplementation | No effect - modulation | systemic inflammation | Human | adolescent patients with Vit D insufficiency | Not specified | The effects of Vitamin D on Keratoconus progression. |
| vitamin D supplementation | No effect - investigate the effect | systemic markers of inflammation | Human | hypertensive patients | 2800 IU of vitamin D (frequency not specified). | Randomized trial of vitamin D versus placebo supplementation on markers of systemic inflammation in hypertensive patients.cited 6× |
| Vitamin D supplementation | No effect - may improve | TB inflammation | Human | — | Not specified | Association of vitamin D with HIV infected individuals, TB infected individuals, and HIV-TB co-infected individuals: a systematic review and meta-analysis.cited 1× |
| vitamin D supplementation | No effect - main outcomes have been patient-focused without investigating | underlying inflammation | Human | adults | 125 µg daily | A 12-week double-blind randomised controlled trial investigating the effect of dietary supplementation with 125cited 2× |
| Topical treatments like corticosteroids and vitamin D analogs | Decreases - reducing | inflammation | Human | — | Not specified | An Overview of Contemporary and Future Therapeutic Strategies for Scalp Psoriasis.cited 2× |
| Supplementation with vitamin D to adequate levels | Decreases - beneficial in improving | PVAT macrophage infiltration and local inflammation | Human | — | Not specified | Sirtuin-1 and Its Relevance in Vascular Calcification.cited 46× |
| vitamin D and magnesium co-supplementation | No effect - test the effects | inflammation | Human | obese women | — | Effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammatory biomarkers, and SIRT1 in obese women: a study protocol for a double-blind, randomized, placebo-controlled trial.cited 16× |
| vitamin D and magnesium co-supplementation | No effect - may provide a new adjuvant therapy through modulation | inflammation | Human | obese women | — | Effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammatory biomarkers, and SIRT1 in obese women: a study protocol for a double-blind, randomized, placebo-controlled trial.cited 16× |
| vitamin D | No effect - evaluate the individual effects | inflammation | Human | 108 obese women | — | Effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammatory biomarkers, and SIRT1 in obese women: a study protocol for a double-blind, randomized, placebo-controlled trial.cited 16× |
| vitamin D | Decreases - have anti-inflammatory and anti-depressant effects | inflammation and depressive symptoms | Human | — | — | Effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammatory biomarkers, and SIRT1 in obese women: a study protocol for a double-blind, randomized, placebo-controlled trial.cited 16× |
| Vitamin D deficiency | Increases - has been linked to | inflammation | Human | — | — | Effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammatory biomarkers, and SIRT1 in obese women: a study protocol for a double-blind, randomized, placebo-controlled trial.cited 16× |
| vitamin D | Decreases - decrease | auto-aggression-related inflammation | Human | — | Not specified | Immunomodulatory Effect of Vitamin D and Its Potential Role in the Prevention and Treatment of Type 1 Diabetes Mellitus-A Narrative Review.cited 52× |
| vitamin D | No effect - associated with | biological activities of the innate and adaptive immune systems, as well as inflammation | Human | — | Maintain serum 25(OH)D of at least 30 ng/mL (preferred range 40-60 ng/mL). | Association of vitamin D status with COVID-19 and its severity : Vitamin D and COVID-19: a narrative review.cited 43× |
| vitamin D (2000 IU/day) | No effect - neither supplement decreased | biomarkers of inflammation | Human | women ≥55 and men ≥50 years of age | 1 g/day of n-3 FA. | Effects of One Year of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Biomarkers of Systemic Inflammation in Older US Adults.cited 22× |
| Vitamin D | Decreases - decreases | elevated circulating suPAR levels caused by systemic inflammation | Human | — | Not specified | The Perspective of Vitamin D on suPAR-Related AKI in COVID-19.cited 3× |
| vitamin D | Decreases - reduce | expression of biomarkers associated with oxidative stress and inflammation | HumanAnimalMolecular | patients with multiple sclerosis, rheumatoid arthritis, congestive heart failure, Parkinson's disease and Alzheimer's disease | High-dose vitamin D3 (specific amount not provided). | Vitamin D as a potential therapy in amyotrophic lateral sclerosis.cited 36× |
| vitamin D | Decreases - important immune-modulator with anti-inflammatory properties | immune modulation and inflammation | Human | — | Not available | Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature.cited 2× |
| vitamin D | Decreases - anti-inflammatory effects are evident and consistent | inflammation | Human | human adipose tissue | Not specified | Vitamin D and Visceral Obesity in Humans: What Should Clinicians Know?cited 19× |
| vitamin D | No effect - mediating effects on | inflammation | Human | — | Not specified | Vitamin D and bone health: potential mechanisms.cited 159× |
| vitamin D | Decreases - has also anti-inflammatory activity | inflammation | Human | — | Not specified in the abstract. | Changes in pro-inflammatory markers and leucine concentrations in response to Nordic Walking training combined with vitamin D supplementation in elderly women.cited 35× |
| vitamin D | Decreases - reduce inflammation | inflammation | Human | elderly women | Not specified in the abstract. | Changes in pro-inflammatory markers and leucine concentrations in response to Nordic Walking training combined with vitamin D supplementation in elderly women.cited 35× |
| vitamin D | No effect - affects | inflammation | Human | — | Not specified | Vitamin D and Ovarian Cancer: Systematic Review of the Literature with a Focus on Molecular Mechanisms.cited 21× |
| vitamin D | No effect - pro- and anti-inflammatory activity | inflammation | Human | — | Not specified | Diet and Alzheimer's dementia - Nutritional approach to modulate inflammation.cited 68× |
| Vitamin D | Decreases - demonstrated potential benefits in reducing | inflammation | Human | patients with COPD | Not specified | The genomic landscape of chronic obstructive pulmonary disease: Insights from nutrigenomics.cited 1× |
| vitamin D | Decreases - has anti-inflammatory effects | inflammation | Human | — | Not specified | Therapeutic use of vitamin D and its analogues in autoimmunity.cited 15× |
| vitamin D | Decreases - anti-inflammatory actions | inflammation | Human | — | Not specified | Vitamin D deficiency and its role in neurological conditions: A review.cited 65× |
| vitamin D | Decreases - possible role in preventing | inflammation | Human | — | Not specified | The controversial role of vitamin D as an antioxidant: results from randomised controlled trials.cited 62× |
| vitamin D | Decreases - has anti-inflammatory properties | inflammation | Human | — | Not specified | The role of low-level laser therapy in Alzheimer's disease: a review of the potential benefits of vitamin D enhancement. |
| vitamin D | Decreases - reducing | inflammation | HumanAnimal | experimental and human IBD | Not specified | Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review.cited 82× |
| vitamin D | Decreases - anti-inflammatory effects mediated by reduced cytokine and prostaglandin release | inflammation | Human | — | Not specified | Vitamin D in Pain Management.cited 84× |
| Vitamin D (VD) | Decreases - may be associated with reduction | inflammation | Human | patients with ulcerative colitis and Crohn's disease | Not specified | Reflections About Inflammatory Bowel Disease and Vitamins A and D.cited 15× |
| Vitamin D | Decreases - reduce inflammation | inflammation | Human | — | Not specified | The role of vitamins D, B12, C, and K in modulating inflammation and disease management in rheumatoid arthritis: a comprehensive review.cited 2× |
| vitamin D | Decreases - anti-inflammatory properties | inflammation | Human | — | Not specified | Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice.cited 71× |
| vitamin D | Decreases - has an anti-inflammatory effect | inflammation | Human | — | Not specified | The Role of Vitamin D in Supporting Health in the COVID-19 Era.cited 15× |
| vitamin D | Decreases - has anti-inflammatory functions | inflammation | Human | — | Not specified | The Role of Vitamin D in Supporting Health in the COVID-19 Era.cited 15× |
| Vitamin D | Decreases - reduces | inflammation | Human | — | Not specified in the abstract. | Vitamin D Supplementation for Patients with Dysmenorrhoea: A Meta-Analysis with Trial Sequential Analysis of Randomised Controlled Trials. |
| Vitamin D | Decreases - reducing | inflammation | Human | — | Systemic injection of cholecalciferol 200,000 I.U. once monthly for 3 months (Group I); intralesional vitamin D injections (both groups). | Impact of Vitamin D Injection on Keloids and Hypertrophic Scars. |
| vitamin D | Decreases - anti-inflammatory effects | inflammation | Human | — | Not specified | Vitamin D in dementia prevention.cited 58× |
| vitamin D | No effect - influence on | inflammation | Human | — | Not specified | A Personalized Approach to Vitamin D Supplementation in Cardiovascular Health Beyond the Bone: An Expert Consensus by the Italian National Institute for Cardiovascular Research.cited 1× |
| vitamin D | Decreases - potent anti-inflammatory effects | inflammation | Human | — | Not specified | The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management.cited 133× |
| Vitamin D | Decreases - supports the immune system fight TB by inhibiting | Interferon-gamma (IFN-γ) and lowering host inflammation | Human | — | 400,000 IU of injectable vitamin D3, administered in 2 doses. | The role of vitamin D supplementation in augmenting IFN-γ production in response to mycobacterium tuberculosis Infection: A randomized controlled trial.cited 1× |
| vitamin D | No effect - does not change | levels of the inflammation biomarker | Human | patients with ESKD | Not specified | Does Native Vitamin D Supplementation Have Pleiotropic Effects in Patients with End-Stage Kidney Disease? A Systematic Review of Randomized Trials.cited 3× |
| vitamin D | Decreases - could dampen | liver inflammation | Human | — | Not specified | Can skin exposure to sunlight prevent liver inflammation?cited 16× |
| vitamin D | Decreases - reducing lung inflammation | lung inflammation | HumanMolecular | in vitro or animal models | Not specified | Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy.cited 9× |
| vitamin D | Decreases - alleviating | oxidative stress and inflammation | Human | — | 400 IU per day. | Effect of vitamin D on oxidative stress and serum inflammatory factors in the patients with type 2 diabetes.cited 27× |
| Vitamin D | No effect - may alter | persistence of systemic 'sterile' inflammation | Human | — | Not specified in the abstract. | The Effects of Vitamin D Supplementation on Metabolic and Oxidative Stress Markers in Patients With Type 2 Diabetes: A 6-Month Follow Up Randomized Controlled Study.cited 61× |
| vitamin D | No effect - is involved in the pathogenesis of | systemic inflammation | Human | — | Not specified | Vitamin D and type 2 diabetes mellitus (D2).cited 28× |
| vitamin D | Decreases - decrease | vascular inflammation and atherosclerosis | Human | — | Not specified | Potential Beneficial Effects of Vitamin D in Coronary Artery Disease.cited 32× |
| magnesium-zinc-calcium-vitamin D co-supplementation | Decreases - may reduce | biomarkers of inflammation and oxidative stress | Human | women with GDM | Not specified | The effects of magnesium-zinc-calcium-vitamin D co-supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes.cited 90× |
| magnesium-zinc-calcium-vitamin D co-supplementation | No effect - failed to find any significant effect | other biomarkers of inflammation | Human | women with PCOS | 400 mg calcium (plus 100 mg magnesium, 4 mg zinc, and 200 IU vitamin D) twice daily | Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.cited 38× |
| Low vitamin D levels | Increases - enabling | vascular inflammation | Human | — | Not specified | Links between Vitamin D Deficiency and Cardiovascular Diseases.cited 167× |
| Vitamin D deficit | Increases - associated | inflammation | Human | patients with atrial fibrillation | Not specified | Links between Vitamin D Deficiency and Cardiovascular Diseases.cited 167× |
| magnesium + vitamin D (MagD; 360 mg magnesium glycinate + 1000 IU vitamin D 3 × daily) | No effect - no statistically significant treatment effects | markers of inflammation | Human | Owt/Ob participants | 360 mg magnesium glycinate + 1000 IU vitamin D3, three times daily | The effect of combined magnesium and vitamin D supplementation on vitamin D status, systemic inflammation, and blood pressure: A randomized double-blinded controlled trial.cited 23× |
| vitamin D exposure | Decreases - seems to be regulated | systemic low-grade inflammation | Human | — | Not specified | Vitamin D Primary Prevention of Respiratory Infections and Asthma in Early Childhood: Evidence and Mechanisms.cited 8× |
| Dietary fiber and vitamin D supplementation | Decreases - might also be important to decrease | inflammation | Human | CKD | Not specified | Optimal nutrition for predialysis chronic kidney disease.cited 15× |
| vitamin D plus magnesium supplementation | Decreases - has beneficial influences | inflammation | Human | obese women with mild to moderate depressive symptoms | — | Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms.cited 21× |
| 25 dihydroxy vitamin D [25(OH)2D] and 1,25-dihydroxyvitamin D [1,25(OH)2D] | No effect - are essential for | human physiological functions, including damping down inflammation and the excessive intracellular oxidative stresses | Human | human | Not specified | Vitamin D: a Review of its Effects on Epigenetics and Gene Regulation.cited 20× |
| Adequate vitamin D levels | Decreases - reducing | inflammation | Human | — | Not specified | Chronic Atrophic Autoimmune Gastritis: The Evolving Role of Vitamin D. |
| Vitamin D-3 supplementation during pregnancy and lactation | Decreases - reduced | selected EED and systemic inflammation biomarkers | Human | women living with HIV | 3000 IU daily | Effects of Vitamin D-3 Supplementation During Pregnancy and Lactation on Maternal and Infant Biomarkers of Environmental Enteric Dysfunction, Systemic Inflammation, and Growth: A Secondary Analysis of a Randomized Controlled Trial. |
| combination therapy of Vitamin D and dapagliflozin | Decreases - attenuated | inflammation | Animal | HF/HS diet-induced rat model of metabolic syndrome | Not specified | Vitamin D and Dapagliflozin Alleviate Renal Injury and Insulin Resistance in a Diet-Induced Metabolic Syndrome Rat Model. |
| vitamin D and calcium | Decreases - may inhibit | prostaglandin-mediated inflammation and colorectal carcinogenesis pathways | Human | — | 1,200 mg/day | Inflammation Modulation by Vitamin D and Calcium in the Morphologically Normal Colorectal Mucosa of Patients with Colorectal Adenoma in a Clinical Trial.cited 12× |
| supplement containing Ribes nigrum, Boswellia serrata, Vitamin D and Bromelain added to traditional local therapy (nasal spray with cortisone) | Decreases - can be a supporting therapy to modulate | local inflammation in the nose | Human | patients affected by chronic sinusitis | 1 dose daily for 30 days (Treatment 1) or 2 doses daily for 15 days (Treatment 2) | A Supplement with Ribes Nigrum, Boswellia Serrata, Bromelain and Vitamin D to Stop Local Inflammation in Chronic Sinusitis: A Case-Control Study.cited 2× |
| Supplementation with vitamin D coupled with exercise or mild caloric restriction | Decreases - has been shown to improve | inflammation | Human | — | Not mentioned | A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention.cited 32× |
| vitamin D deficiency | Increases - may increase the potential risk | chronic inflammation | Human | obese individuals | Not mentioned | A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention.cited 32× |
| 12 weeks oral supplementation of vitamin D | No effect - did not significantly affect | serum biomarkers of inflammation | Human | patients with type 2 DM | 5000 IU/day of vitamin D (indirectly affecting calcium levels). | Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes.cited 139× |
| A diet supplemented with vitamin D and marine omega-3 fatty acids | Increases - promoting | the resolution of inflammation | Human | — | 2000 IU/day of vitamin D | The effect of vitamin D and omega-3 fatty acid supplementation on pain prevalence and severity in older adults: a large-scale ancillary study of the VITamin D and OmegA-3 triaL (VITAL).cited 5× |
| vitamin D deficiency | Increases - is also associated with | chronic inflammation | Human | — | Not Assessed | Bariatric surgery and vitamin D: key messages for surgeons and clinicians before and after bariatric surgery.cited 8× |
| vitamin D deficiency | No effect - plays a role in modulating | inflammation | Human | individuals afflicted with psychiatric disorders | Not specified | Severe Vitamin D Deficiency-A Possible Cause of Resistance to Treatment in Psychiatric Pathology.cited 6× |
| Vitamin D deficiency | Increases - resulting in enhanced | inflammation | Human | — | Not specified | Vitamin D-Parathyroid Hormone-Fibroblast Growth Factor 23 Axis and Cardiac Remodeling. |
| vitamin D deficiency | Increases - links to | inflammation-obesity-cancer risk | Human | — | Not specified | Mapping the landscape of vitamin D in cancer studies: a systematic global investigation. |
| Vitamin D deficiency | Increases - was associated with a higher degree of | systemic inflammation | Human | postcritical COVID-19 patients | Not specified | Relationship Between Vitamin D Levels with In-Hospital Complications and Morphofunctional Recovery in a Cohort of Patients After Severe COVID-19 Across Different Obesity Phenotypes.cited 1× |
| forced dosing regimen of vitamin D | No effect - evaluating changes | inflammation | Human | patients undergoing omega-loop gastric bypass surgery | Loading dose (100,000 IU on day 1, then 2 and 4 weeks post-surgery) followed by maintenance dose (3420 IU/day). Control group received placebo followed by 3420 IU/day. | The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial.cited 11× |
| Weight loss and vitamin D supplementation | Decreases - may act synergistically to reduce | levels of meta-inflammation | Human | obese subjects with vitamin D deficiency | 50,000 IU vitamin D weekly | Effect of vitamin D supplementation along with weight loss diet on meta-inflammation and fat mass in obese subjects with vitamin D deficiency: A double-blind placebo-controlled randomized clinical trial.cited 31× |
| Sarcomeal® supplement plus vitamin D | Decreases - reducing | inflammation | Human | diabetic people who also have sarcopenia | 1000 IU of vitamin D daily. | The effect of Sarcomeal® oral supplementation plus vitamin D3 on muscle parameters and metabolic factors in diabetic sarcopenia patients: study protocol of a randomized controlled clinical trial. |
| vitamin D and omega-3 fatty acid co-supplementation | No effect - examines the effects | inflammation and nutritional status | Human | colorectal cancer patients | Two 330 mg omega-3 fatty acid capsules daily | Randomized Study Design to Test Effects of Vitamin D and Omega-3 Fatty Acid Supplementation as Adjuvant Therapy in Colorectal Cancer Patients.cited 6× |
| active vitamin D metabolite 1,25-dihydroxyvitamin D | Decreases - regulates | immunopathological inflammation | HumanMolecular | in vitro cell cultures | Not specified | Vitamin D in the prevention or treatment of COVID-19.cited 11× |
| supplementation with vitamin D | Decreases - demonstrated its protective effects by decreasing | inflammation | AnimalMolecular | cardiovascular disease (CVD) models | Not specified | Vitamin D as a modulator of molecular pathways involved in CVDs: Evidence from preclinical studies.cited 4× |